Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 238

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism: Pooled Analysis of 8 Case-control Studies Including 2310 Cases and 3204 Controls

Rosendaal, Frits, Cattaneo, Marco, Margaglione, Maurizio, De Stefano, Valerio, Cumming, Tony, Arruda, Valder, Hillarp, Andreas, Reny, Jean-Luc, Emmerich, Joseph, the study group for pooled-analysis in venous thromboembolism · 2001 · Thrombosis and Haemostasis

Abstract

Summary: Factor V Leiden and factor II G20210A mutations are two frequent genetic risk factors involved in venous thromboembolism (VTE). The goal of this pooled analysis of 8 case-control studies, comprising a total of 2310 cases and 3204 controls, was to precisely estimate the risk of VTE in patients bearing both mutations (double heterozygotes). Odds ratios for VTE were 4.9 (95% CI; 4.1-5.9) for the factor V Leiden and 3.8 (3.0-4.9) for the factor II G20210A mutation. Fifty-one cases (2.2%) and none of the controls were double heterozygotes. The odds ratio for venous thrombosis in double heterozygotes was 20.0 (11.1-36.1). Twelve percent of patients heterozygous for factor V Leiden were also heterozygous for factor II G20210A and conversely 23% of patients heterozygous for factor II G20210A were also heterozygous for factor V Leiden. Furthermore, in this large population we analyzed the effect of oral contraceptive (OC) in women carrying one of these mutations. Odds ratio for VTE associated with OC was 2.29 (1.72-3.04). In factor V Leiden carriers using OC, the odds ratio for VTE was 10.25 (5.69-18.45). The odds ratio of the association of factor II mutation and OC use was 7.14 (3.39-15.04). Finally, we also confirmed that the frequency of factor V Leiden was lower in patients with pulmonary embolism than in patients with deep vein thrombosis without PE (odds ratio 0.69). Conversely, factor II G20210A mutation was equally balanced in both patient groups.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0037-1616136

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 238

Metadata

Authors
Rosendaal, F., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Hillarp, A., Reny, J.-L., Emmerich, J., & the study group for pooled-analysis in venous thromboembolism
Venue
Thrombosis and Haemostasis
Published
2001
Volume
86
Issue
09
Pages
809-816
ISSN
  • 0340-6245 (ISSN-L)
  • 2567-689X
OpenAlex
W4322703218
Cited by
238
References
1
FWCI
7.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism: Pooled Analysis of 8 Case-control Studies Including 2310 Cases and 3204 Controls. https://app.cochat.ai/papers/10.1055/s-0037-1616136
The paper
Rosendaal, F., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Hillarp, A., Reny, J.-L., Emmerich, J., & the study group for pooled-analysis in venous thromboembolism. (2001). Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism: Pooled Analysis of 8 Case-control Studies Including 2310 Cases and 3204 Controls. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0037-1616136

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.